Anti-osteoporosis drugs and reduction of mortality in cancer patients

被引：0
|
作者：
Chandran, Manju [1 ,2 ,3 ,6 ]
Ching, Lau Tang [4 ,5 ]
机构：
[1] Singapore Gen Hosp, Dept Endocrinol, Osteoporosis & Bone Metab Unit, Singapore, Singapore
[2] Duke NUS Med Sch, Singapore, Singapore
[3] Asia Pacific Consortium Osteoporosis APCO, Singapore, Singapore
[4] Natl Univ Hlth Syst, Dept Rheumatol, Singapore, Singapore
[5] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore
[6] Singapore Gen Hosp, Osteoporosis & Bone Metab Unit, Outram Rd, Singapore 169608, Singapore
来源：
ANNALS ACADEMY OF MEDICINE SINGAPORE | 2024年 / 53卷 / 01期
关键词：
cancer; elderly; mortality; osteoporosis; osteoporotic vertebral fracture; ZOLEDRONIC ACID;
D O I：
10.47102/annals-acadmedsg.20244
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [31] Anti-osteoporosis activity of casticin in ovariectomized rats
    Zhang, Dong
    Li, Jianmin
    Li, Xuejia
    Liu, Wanxin
    Yu, Ying
    Sun, Hao
    Wu, Jiajun
    Ge, Zhichao
    Lv, Kai
    Shao, Yanting
    Wang, Shuqiang
    Ye, Xiaojian
    TOXICOLOGY RESEARCH, 2024, 13 (02)
  • [32] New anti-osteoporosis drug target identified
    Starling, Shimona
    NATURE REVIEWS ENDOCRINOLOGY, 2021, 17 (01) : 5 - 5
  • [33] Adverse Reactions Associated with Anti-Osteoporosis Treatments
    El Ferjani, S.
    Zaiem, A.
    Kaabi, W.
    Lakhoua, G.
    Sahnoun, R.
    Lakhal, M.
    Daghfous, R.
    El Aidli, S.
    DRUG SAFETY, 2013, 36 (09) : 924 - 924
  • [34] Effects of anti-osteoporosis medications on fracture healing
    Jørgensen N.R.
    Schwarz P.
    Current Osteoporosis Reports, 2011, 9 (3) : 149 - 155
  • [35] Low Bone Mineral Density and Calcium Levels as Risks for Mortality in Patients with Self-Discontinuation of Anti-Osteoporosis Medication
    Hsu, Chun-Sheng
    Chang, Shin-Tsu
    Cheng, Yuan-Yang
    Lee, Hsu-Tung
    Chen, Chih-Hui
    Deng, Ya-Lian
    Hsu, Chiann-Yi
    Chen, Yi-Ming
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (01)
  • [36] Anti-Cancer, Anti-Osteoporosis, and Molecular Docking Studies of Novel Chalcone and Epoxy Chalcone
    Hussein, Kawkab
    Shihab, Nezar
    Saeed, Bahjat
    BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY, 2022, 12 (05): : 6668 - 6685
  • [37] New anti-osteoporosis drug target identified
    Shimona Starling
    Nature Reviews Endocrinology, 2021, 17 : 4 - 5
  • [38] Considerations regarding adherence of anti-osteoporosis therapy
    Lagari, Violet S.
    McAninch, Elizabeth
    Baim, Sanford
    POSTGRADUATE MEDICINE, 2015, 127 (01) : 92 - 98
  • [39] PRESCRIPTION OF ANTI-OSTEOPOROSIS DRUGS DURING 2004-2007-A NATIONWIDE REGISTER STUDY IN NORWAY
    Devold, H.
    Duong, M.
    Tverdal, A.
    Furi, K.
    Meyer, H. E.
    Falch, J. A.
    Sogaard, A. J.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S298 - S298
  • [40] Repurposing anti-osteoporosis drugs for autoimmune diseases: A two-sample Mendelian randomization study
    Xiang, Pan
    Yang, Chengyuan
    Shen, Ruoyi
    Huang, Xiaoxiong
    Huang, Xuerong
    Cheng, Qi
    Luo, Zongping
    Zhang, Qin
    HELIYON, 2024, 10 (14)
12345